Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • On the Market
  • Published:

Blood substitutes — a moving target

Nature Medicine volume 1, pages 1212–1215 (1995)Cite this article

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Diamond, L.K. A history of blood transfusion. in Blood, Pure and Eloquent (ed. Wintrobe, M.M.) 659 (McGraw-Hill, New York, 1980).

    Google Scholar 

  2. Winslow, R.M. Hemoglobin-Based Red Cell Substitutes (Johns Hopkins Press, Baltimore, 1992).

    Google Scholar 

  3. Centers for Disease Control (Atlanta) Morbid. Mortal. Wkly Rep. July, 1993.

  4. HIV and the blood supply: An analysis of crisis decision making (eds Leveton, L.B., Sox, H.C. Jr, Stoto, M.A.). Report of the Committee to Study HIV Transmission Through Blood and Blood Products, National Academy Press, Washington, DC, 1995.

  5. Bowersox, J.C. & Hess, J.R. Combat casualties, blood, and red cell substitutes: A military perspective in 1995. in Blood Substitutes: Physiological Basis of Efficacy (eds Winslow, R.M., Vandegriff, K.D. & Intaglietta, M.) (Birkhaüser, Boston, 1995).

    Google Scholar 

  6. Bickell, W.H. et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. New Engl. J. Med. 331, 1105–1109 (1994).

    Article  CAS  Google Scholar 

  7. NIH Consensus Conference: Perioperative Red Cell Transfusion. JAMA 260, 2700–2703 (1988).

  8. Goodnough, T.L. et al. Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy. New Engl. J. Med. 321, 1163–1168 (1989).

    Article  CAS  Google Scholar 

  9. Mercuriali, F. et al. The potential role of oxygen-carrying products in autologous blood transfusion protocols. Artif. Cells Blood Subs. Immobil. Biotech. 22, 245–251 (1994).

    Article  CAS  Google Scholar 

  10. Tartter, P.I. Immunologic effects of blood transfusion. Immunol. Invest. 24, 277–288 (1995).

    Article  CAS  Google Scholar 

  11. Christopherson, R. et al. Low postoperative hematocrit is associated with cardiac ischemia in high-risk patients. Anesthesiology 75, A99 (1991).

    Article  Google Scholar 

  12. Horowitz, B., Prince, A.M., Hamman, J. & Watklevicz, C. Viral safety of solvent/detergent-treated blood products. Blood Coag. Fibrinol. 5 (suppl. 3), S21–S28, (1994).

    Article  Google Scholar 

  13. Corash, L. Decontamination of red cell components. in Sickle Cell Disease and Thalassaemias: New Trends in Therapy (eds Beuzard, Y., Lubin, B. & Rosa, J.) Vol. 234, 275–284 (Colloque INSERM/John Libbey Eurotext, Montrouge, France, 1995).

    Google Scholar 

  14. Winslow, R.M. & Chapman, K.W. Pilot-scale preparation of hemoglobin solutions. in Hemoglobins Part B: Biochemical and Analytical Methods (eds Everse, J., Vandegriff, K.D. & Winslow, R.M.) Meth. Enzym. 231, 316 (1994).

    Google Scholar 

  15. Schumacher, M.A., Dixon, M.M., Kluger, R., Jones, R.T. & Brennan, R.G. Allosteric transition intermedidates modelled by crosslinked haemoglobins. Nature 375, 84–87 (1995).

    Article  CAS  Google Scholar 

  16. Nakai, K. et al. Acellular and cellular hemoglobin solutions as a vasoconstrictor factor. Artif. Cells Blood Subs. Immobil. Biotech. 22, 559–564 (1994).

    Article  CAS  Google Scholar 

  17. Rioux, F. et al. Recombinant human hemoglobin inhibits both constitutive and cytosine-induced nitric oxide-mediated relaxation of rabbit isolated aortic rings. J. cardiovasc. Pharmac. 24, 229–237 (1994).

    Article  CAS  Google Scholar 

  18. Flaim, S.F., Hazard, D.R., Hogan, J. & Peters, R.M. Characterization and mechanism of side-effects of Imagent BP (highly concentrated fluorocarbon emulsion) in swine. Invest. Radial. 26 (suppl.) S122–S124; discussion S125–S128 (1991).

    Article  CAS  Google Scholar 

  19. Rudolph, A.G., Cliff, R.O., Spargo, B.J. & Spielberg, H. Transient changes in the mononuclear phagocyte system following administration of the blood substitute liposome-encapsulated haemoglobin. Biomaterials 15, 796–804 (1994).

    Article  CAS  Google Scholar 

  20. Tsai, A.G., Kerger, H. & Intaglietta, M. Microcirculatory consequences of blood substitution with aa-hemoglobin. in Blood Substitutes: Physiological Basis of Efficacy (eds Winslow, R.M., Vandegriff, K.D. & Intaglietta, M.) (Birkhaüser, Boston, 1995).

    Google Scholar 

  21. Looker, D.D., Mathews, A.J., Neway, J.O. & Stetler, G.L. Expression of recombinant human hemoglobin in Escherichia coli . in Hemoglobins Part B: Biochemical and Analytical Methods (eds Everse, J., Vandegriff, K.D. & Winslow, R.M.) Meth. Enzym. 231, 364–373 (1994).

    Chapter  Google Scholar 

  22. Ogden, J.E., Harris, R. & Wilson, M.T. Production of recombinant human hemoglobin A in Saccharomyces cerevisiae . in Hemoglobins Part B: Biochemical and Analytical Methods. (eds Everse, J., Vandegriff, K.D. & Winslow, R.M.) Meth. Enzym. 231, 374–389 (1994).

    Chapter  Google Scholar 

  23. Reilly, M.P. et al. Preparation of recombinant hemoglobin in transgenic mice. in Hemoglobins Part B: Biochemical and Analytical Methods (eds Everse, J., Vandegriff, K.D. & Winslow, R.M.) Meth. Enzym. 231, 403–434 (1994).

    Chapter  Google Scholar 

  24. Logan, J.S. & Martin, M.J. Transgenic swine as recombinant production systems for human hemoglobin. in Hemoglobins Part B: Biochemical and Analytical Methods. (eds Everse, J., Vandegriff, K.D. & Winslow, R.M.) Meth. Enzym. 231, 364–373 (1994).

    Google Scholar 

  25. Gould, S. Oral presentation, American College of Surgeons, Annual Meeting, New Orleans, Louisiana, 26 October 1995.

  26. Tomasulo, P. Transfusion alternatives: Impact on blood banking worldwide. in Blood Substitutes: Physiological Basis of Efficacy (eds Winslow, R. M., Vandegriff, K.D. & Intaglietta, M.) (Birkhaüser, Boston, 1995).

    Google Scholar 

  27. Hirschl, R.B. et al. Liquid ventilation in adults, children, and full-term neonates: Preliminary report. Lancet (in the press).

  28. Kaufman, R.J. Clinical development of perfluoro-carbon-based emulsions as red cell substitutes. in Blood Substitutes: Physiological Basis of Efficacy (eds Winslow, R. M., Vandegriff, K.D. & Intaglietta, M.) (Birkhaüser, Boston, 1995).

    Google Scholar 

  29. Lorente, J.A. et al. L-Arginine pathway in the sepsis syndrome. Crit. Care Med. 21, 1287–1295 (1993).

    Article  CAS  Google Scholar 

  30. Suit, H. Tumor oxygenation and radiosensitivity. in Blood Substitutes: Physiological Basis of Efficacy (eds Winslow, R.M., Vandegriff, K.D. & Intaglietta, M.) (Birkhaüser, Boston, 1995).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, School of Medicine, University of California, San Diego, California, USA

    Robert M. Winslow

  2. Veterans Affairs Medical Center (111-E), 3350 La Jolla Village Drive, San Diego, California, 92161, USA

    Robert M. Winslow

Authors
  1. Robert M. Winslow
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Winslow, R. Blood substitutes — a moving target. Nat Med 1, 1212–1215 (1995). https://doi.org/10.1038/nm1195-1212

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1195-1212

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing